Congenital adrenal hyperplasia historical perspective: Difference between revisions
Jump to navigation
Jump to search
| Line 13: | Line 13: | ||
* In 1855, Thomas Addison defined the clinical features and autopsy findings in 11 cases of diseases of the suprarenal capsules, and half of them were tuberculous in origin. | * In 1855, Thomas Addison defined the clinical features and autopsy findings in 11 cases of diseases of the suprarenal capsules, and half of them were tuberculous in origin. | ||
* In 1856, In adrenalectomy experiments, Brown-Séquard | * In 1856, In adrenalectomy experiments, Brown-Séquard found that the adrenal glands are nessesary for life. | ||
* In 1896, William Osler prepared an oral glycerin extract derived from pig adrenals and showed that it had clinical benefit in patients with Addison disease. | |||
* In 1905, Bulloch and Sequeira described patients with congenital adrenal hyperplasia. | |||
* In 1932, Harvey Cushing associates the polyglandular syndrome of pituitary basophilism, which he first described in 1912, with hyperactivity of the pituitary-adrenal glands. | |||
* In 1936,The concept of stress and its effect on pituitary-adrenal function are described by Selye. | |||
* In 1937-1952,Isolation and structural characterization of adrenocortical hormones are reported by Kendall and Reichstein. | |||
* In 1943, Li and colleagues isolate pure adrenocorticotropic hormone from sheep pituitary. | |||
In | * In 1950, Hench, Kendall, and Reichstein share the Nobel Prize in Medicine for describing the anti-inflammatory effects of cortisone in patients with rheumatoid arthritis | ||
From 1980-present the molecular era: cloning and functional characterization of steroid receptors, steroidogenic enzymes, and adrenal transcription factors are reported, and the molecular basis for human adrenal diseases is defined. | * In 1953,Isolation and analysis of the structure of aldosterone are reported by Simpson and Tait. In 1956, Conn describes primary aldosteronism. In 1981, Characterization and synthesis of corticotropin-releasing hormone are reported by Vale. | ||
* From 1980-present the molecular era: cloning and functional characterization of steroid receptors, steroidogenic enzymes, and adrenal transcription factors are reported, and the molecular basis for human adrenal diseases is defined. | |||
==References== | ==References== | ||
Revision as of 18:22, 6 July 2017
|
Congenital adrenal hyperplasia main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Historical Perspective
Congenital adrenal hyperplasia first time seen in 1865 by an Italian pathologist in a man at autopsy, who had big adrenal glands and female internal organs.[1][2][3][4]
- In 1563, Eustachius described the adrenals and then published by Lancisi in 1714.
- In 1849, Thomas Addison, found on a bronzed appearance associated with the adrenal glands called melasma suprarenale while searching for the cause of pernicious anemia.
- In 1855, Thomas Addison defined the clinical features and autopsy findings in 11 cases of diseases of the suprarenal capsules, and half of them were tuberculous in origin.
- In 1856, In adrenalectomy experiments, Brown-Séquard found that the adrenal glands are nessesary for life.
- In 1896, William Osler prepared an oral glycerin extract derived from pig adrenals and showed that it had clinical benefit in patients with Addison disease.
- In 1905, Bulloch and Sequeira described patients with congenital adrenal hyperplasia.
- In 1932, Harvey Cushing associates the polyglandular syndrome of pituitary basophilism, which he first described in 1912, with hyperactivity of the pituitary-adrenal glands.
- In 1936,The concept of stress and its effect on pituitary-adrenal function are described by Selye.
- In 1937-1952,Isolation and structural characterization of adrenocortical hormones are reported by Kendall and Reichstein.
- In 1943, Li and colleagues isolate pure adrenocorticotropic hormone from sheep pituitary.
- In 1950, Hench, Kendall, and Reichstein share the Nobel Prize in Medicine for describing the anti-inflammatory effects of cortisone in patients with rheumatoid arthritis
- In 1953,Isolation and analysis of the structure of aldosterone are reported by Simpson and Tait. In 1956, Conn describes primary aldosteronism. In 1981, Characterization and synthesis of corticotropin-releasing hormone are reported by Vale.
- From 1980-present the molecular era: cloning and functional characterization of steroid receptors, steroidogenic enzymes, and adrenal transcription factors are reported, and the molecular basis for human adrenal diseases is defined.
References
- ↑ Delle Piane L, Rinaudo PF, Miller WL (2015). "150 years of congenital adrenal hyperplasia: translation and commentary of De Crecchio's classic paper from 1865". Endocrinology. 156 (4): 1210–7. doi:10.1210/en.2014-1879. PMID 25635623.
- ↑ Melmed, Shlomo (2016). Williams textbook of endocrinology. Philadelphia, PA: Elsevier. ISBN 978-0323297387.=
- ↑ HENCH PS, KENDALL EC (1949). "The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis". Proc Staff Meet Mayo Clin. 24 (8): 181–97. PMID 18118071.
- ↑ Biglieri EG, Herron MA, Brust N (1966). "17-hydroxylation deficiency in man". J. Clin. Invest. 45 (12): 1946–54. doi:10.1172/JCI105499. PMC 292880. PMID 4288776.